- No file added yet -
Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients With Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO Trial
figure
posted on 2020-09-02, 14:21 authored by Jin Li, Weijian Guo, Yuxian Bai, Yanhong Deng, Lei Yang, Zhendong Chen, Haijun Zhong, Ruihua Xu, Hongming Pan, Yongqian Shu, Ying Yuan, Jianfeng Zhou, Nong Xu, Tianshu Liu, Dong Ma, Changping Wu, Ying Cheng, Jianming Xu, Donghui Chen, Wei Li, Sanyuan Sun, Zhuang Yu, Peiguo Cao, Lin Shen, Haihui Chen, Shubin Wang, Hongbing Wang, Songhua Fan, Xiaojun Guo, Ning Wang, Rubing Han, Bin Zhang, Shukui QinThe above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.
